Molecular Partners
Schlieren-Zürich, Switzerland · Science and Engineering
Source
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
Nov 2025
Work here? Claim this profile
#Intellectual Property of DARPins
#Immunology and other Indications
#Ophthalmology
#Collaborations with leading pharmaceutical companies
#Oncology
Overview
About Molecular Partners AG
Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics. The company attracts talented individuals who share the passion to develop breakthrough medicines for serious diseases. Molecular Partners has compounds in various stages of clinical and preclinical development and several more in the research stage, with a current focus on oncology and virology. The company conducts research and development both internally and in partnerships with leading pharmaceutical companies and is backed by top biotech investors.
Contact Details
info@molecularpartners.com
Schlieren-Zürich, Switzerland
Founded
2004
Employees
100-150
Categories
Keywords
#Intellectual Property of DARPins
#Immunology and other Indications
#Ophthalmology
#Collaborations with leading pharmaceutical companies
#Oncology
Companies teams usually look at after Molecular Partners
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.